Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TAREK ELDAWY

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1669416459
CMS profile
166338
Location
OVIEDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$8,653.13

253 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Ipsen Biopharmaceuticals, Inc $2,436.16 4
Novartis Pharmaceuticals Corporation $1,419.44 30
AstraZeneca Pharmaceuticals LP $607.87 25
Celgene Corporation $379.38 18
PFIZER INC. $312.23 16
Eisai Inc. $262.85 12
Merck Sharp & Dohme LLC $238.94 12
Daiichi Sankyo Inc. $212.14 10
Janssen Biotech, Inc. $184.81 10
GENZYME CORPORATION $178.21 8
ABBVIE INC. $171.95 9
SOBI, INC $154.15 6
Alexion Pharmaceuticals, Inc. $153.39 5
Gilead Sciences, Inc. $149.81 8
Incyte Corporation $148.74 7
Bayer Healthcare Pharmaceuticals Inc. $119.06 5
Amgen Inc. $112.00 1
PharmaEssentia USA Corporation $104.45 4
Blueprint Medicines Corporation $93.71 5
Genentech USA, Inc. $82.03 4
Genmab U.S., Inc. $81.49 3
TerSera Therapeutics LLC $74.09 4
Lilly USA, LLC $71.80 3
BeiGene USA, Inc. $60.01 3
SERVIER PHARMACEUTICALS LLC $59.81 3
Astellas Pharma US Inc $56.07 3
ADC Therapeutics America, Inc. $53.62 3
Takeda Pharmaceuticals U.S.A., Inc. $52.57 2
E.R. Squibb & Sons, L.L.C. $50.80 3
SpringWorks Therapeutics, Inc. $50.51 2
Karyopharm Therapeutics Inc. $49.19 2
Menarini Silicon Biosystems, Inc. $43.81 2
Mirati Therapeutics, Inc. $42.64 2
JAZZ PHARMACEUTICALS INC. $41.80 2
Rigel Pharmaceuticals, Inc. $40.67 2
ARRAY BIOPHARMA INC $39.37 2
Fennec Pharmaceuticals, Inc. $33.79 2
Tempus AI, Inc $24.74 1
Janssen Pharmaceuticals, Inc $24.13 1
Exelixis Inc. $24.06 1
Dendreon Pharmaceuticals LLC $23.36 1
Agios Pharmaceuticals, Inc. $23.28 1
Stemline Therapeutics Inc. $22.53 1
GlaxoSmithKline, LLC. $20.80 1
Pharmacosmos Therapeutics Inc. $18.34 1
Regeneron Healthcare Solutions, Inc. $16.97 1
Kyowa Kirin, Inc. $16.33 1
PUMA BIOTECHNOLOGY, INC. $15.23 1

Page 5 of 6; records 201–250 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TAREK ELDAWY

NPI 1669416459 · CMS profile ID 166338

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

OVIEDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 6; records 201–250 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669416459?year=2024&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TAREK ELDAWY, NPI 1669416459, CMS profile ID 166338. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 6; records 201–250 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669416459?year=2024&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). TAREK ELDAWY, NPI 1669416459, CMS profile ID 166338. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 6; records 201–250 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669416459?year=2024&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
TAREK ELDAWY, NPI 1669416459, CMS profile ID 166338, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 6; records 201–250 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1669416459?year=2024&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

253 matching records · $8,653.13 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 253 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 253.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Astellas Pharma US Inc $16.5903/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139266228 CMS
Blueprint Medicines Corporation $13.8503/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147455739 CMS
Novartis Pharmaceuticals Corporation $99.7003/15/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086831907 CMS
GENZYME CORPORATION $27.4403/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140004940 CMS
AstraZeneca Pharmaceuticals LP $18.0503/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104506048 CMS
Karyopharm Therapeutics Inc. $26.8003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145537669 CMS
GENZYME CORPORATION $18.2803/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140004942 CMS
Merck Sharp & Dohme LLC $21.6603/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141710977 CMS
ABBVIE INC. $11.7903/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103684271 CMS
Celgene Corporation $25.0903/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101144671 CMS
Pharmacosmos Therapeutics Inc. $18.3403/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154821507 CMS
Eisai Inc. $20.6802/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110784915 CMS
BeiGene USA, Inc. $24.3702/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120868430 CMS
Celgene Corporation $14.0302/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101144667 CMS
Rigel Pharmaceuticals, Inc. $16.2702/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145201435 CMS
Novartis Pharmaceuticals Corporation $19.9602/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086831875 CMS
Lilly USA, LLC $29.0002/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135455303 CMS
Eisai Inc. $24.9102/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110784909 CMS
Gilead Sciences, Inc. $15.1402/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133829795 CMS
PharmaEssentia USA Corporation $23.9202/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137305567 CMS
Novartis Pharmaceuticals Corporation $99.7002/16/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086831905 CMS
PharmaEssentia USA Corporation $31.5002/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137305565 CMS
TerSera Therapeutics LLC $19.0702/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144718818 CMS
Merck Sharp & Dohme LLC $24.5102/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141710961 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.7702/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144957041 CMS
PFIZER INC. $28.8002/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131187405 CMS
Celgene Corporation $27.7002/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101144669 CMS
PFIZER INC. $21.5702/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131187408 CMS
PFIZER INC. $11.9202/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131276374 CMS
Daiichi Sankyo Inc. $23.4602/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089418644 CMS
Janssen Biotech, Inc. $19.0702/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078470090 CMS
Gilead Sciences, Inc. $21.2001/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133829793 CMS
Incyte Corporation $18.0701/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141247008 CMS
Alexion Pharmaceuticals, Inc. $83.9901/29/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093969122 CMS
AstraZeneca Pharmaceuticals LP $21.9601/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104271499 CMS
Eisai Inc. $19.7901/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110784917 CMS
Merck Sharp & Dohme LLC $19.0301/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141873415 CMS
Astellas Pharma US Inc $23.1501/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139286478 CMS
Novartis Pharmaceuticals Corporation $23.4801/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086831873 CMS
AstraZeneca Pharmaceuticals LP $29.3501/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104307818 CMS
PFIZER INC. $17.4601/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130964780 CMS
PUMA BIOTECHNOLOGY, INC. $15.2301/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113856081 CMS
Agios Pharmaceuticals, Inc. $23.2801/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149646136 CMS
PFIZER INC. $25.0101/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131136402 CMS
Janssen Biotech, Inc. $16.3901/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078469963 CMS
Daiichi Sankyo Inc. $24.3001/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089418650 CMS
AstraZeneca Pharmaceuticals LP $23.4301/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105717632 CMS
GENZYME CORPORATION $27.8401/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1140004936 CMS
Merck Sharp & Dohme LLC $21.4601/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141873215 CMS
Alexion Pharmaceuticals, Inc. $20.4801/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093982388 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,516.48 34
PY2020 $3,148.16 4
PY2021 $295.42 9
PY2022 $4,843.18 44
PY2023 $7,802.24 93
PY2024 $8,653.13 253
PY2025 $8,167.00 256

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $16,750.00 3
PY2022 Principal investigator $32,722.02 9
PY2021 Principal investigator $14,349.53 7
PY2020 Principal investigator $29,488.30 7
PY2019 Principal investigator $191,044.85 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,000.00 09/12/2023 Non-covered Recipient Entity
STUDER FAMILY CHILDRENS HOSPITAL
A randomized double blind placebo controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive HER2 negative advanced breast cancer who received no prior hormonal therapy for advanced disease No dispute reported 06/30/2026 1017238707
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $500.00 06/07/2023 Covered Recipient Teaching Hospital
Ascension Sacred Heart Pensacola
Phase III Study Adj GEJ & Esoph (US EU) (mono) - A Randomized, Multicenter, Double-Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal or Gastroesophageal Junction Cancer No dispute reported 06/30/2026 1027467115
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $15,250.00 04/20/2023 Covered Recipient Teaching Hospital
Ascension Sacred Heart Pensacola
PhIII Stage 3/4 Resectable Mel Adj Rela+Nivo vs Nivo - A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Relatlimab andNivolumab Fixed-dose Combination versus Nivolumab Monotherapy after Complete Resection of Stage III-IV Melanoma [ No dispute reported 06/30/2026 1027479761